Overview

Study of FlutiForm® Versus Fluticasone Plus Formoterol in Adult Subjects With Severe Asthma

Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The study compares the efficacy and safety of FlutiForm® vs Flixotide® plus Foradil® in the treatment of severe persisent asthma in adult subjects.
Phase:
Phase 3
Details
Lead Sponsor:
Mundipharma Research Limited
Treatments:
Fluticasone
Formoterol Fumarate
Xhance